GSK: Result Summaries: Compounds

Result Summaries: denagliptin

Result Summaries for denagliptin
GSK Study ID	Phase	Title	Summary (Download)
100925	Phase 2	A 12-Week, Parallel-Group, Double-Blind, Randomised, Placebo-Controlled, Multicentre, Dose Ranging Study toEvaluate the Efficacy, Safety and Tolerability of GW823093 (2.5mg, 7.5mg, 15mg, 30mg and 45mg), AdministeredOrally, Once Daily, as Monotherapy in Subjects With Type 2 Diabetes Mellitus foll ... (0 citation(s))
102761	Phase 1	An Open-Label, Randomized Study with 3 Cohorts of 3-Way Crossovers to Investigate the Safety, Tolerability and Pharmacokinetics of XXmg Oral Doses of Investigational Drug and 500mg BID Oral Doses of Metformin (Cohort 1), 8mg Oral Doses of Rosiglitazone (Cohort 2), and 45mg Oral Doses of Pioglita ... (0 citation(s))